Biomedical nanotechnology has emerged as a revolutionary frontier in the pharmaceutical field, leveraging the unique properties of nanoscale materials to enhance drug delivery, diagnostics, and therapy. By manipulating matter at the molecular and atomic levels, nanotechnology offers unprecedented precision in targeting specific cells and tissues, minimizing side effects, and maximizing therapeutic efficacy. In drug delivery, nanoparticles can encapsulate pharmaceutical agents, facilitating their controlled release and improving bioavailability.
Additionally, nanoscale carriers enable the delivery of drugs across biological barriers, such as the blood-brain barrier, expanding treatment possibilities for neurological disorders. Moreover, diagnostic applications benefit from the sensitivity of nanomaterials, allowing for early disease detection through imaging techniques at the molecular level. The integration of biomedical nanotechnology into the pharmaceutical landscape holds the promise of personalized medicine, where treatments can be tailored to individual patients based on their unique molecular profiles, ushering in a new era of more effective and targeted therapies.
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Precision diagnostics: Effectiveness of innovative imaging technologies for early detection of lung cancers
Huiqin Yang, ICON Clinical Research Ltd, United Kingdom
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Design and characterization of gum arabic buccal films for protein drug delivery
Krisztian Pamlenyi, University of Szeged, Hungary